Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)
| 0.5999 Delayed Data As of Jun 06 |  +0.0086 / +1.45%Today’s Change | 0.45 Today|||52-Week Range 12.60 | -60.01% Year-to-Date |
Latest FRTX News | Press Releases
No recent news for Fresh Tracks Therapeutics Inc.
Today’s Trading
| Previous close | 0.59 |
| Today’s open | 0.60 |
| Day’s range | 0.58 - 0.60 |
| Volume | 506 |
| Average volume (3 months) | 612,105 |
| Market cap | $3.4M |
Data as of 3:58pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | +66.02% |
| Earnings growth (this year) | +27.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,618.56% |
| P/E ratio | NM |
| Price/Sales | 0.61 |
| Price/Book | 0.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HSTOHistogen Inc | +0.06 | +7.07% |
| PBLAPanbela Therapeutics... | -0.51 | -8.57% |
| CPHIChina Pharma Holding... | -0.02 | -4.78% |
| NAVBNavidea Biopharmaceu... | -0.00 | -5.22% |
Data as of 3:55pm ET, 06/06/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$1.68 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -303.93% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
